Occurrence and removal of estrogens and beta blockers by various processes in wastewater treatment plants

Science of the Total Environment

Volumn 408, Issue 19, 2010, Pages 4257-4269

  Gabet Giraud, V ^a   Miege C ^a   Choubert, J M ^a   Ruel, S Martin ^b   Coquery, M ^a  

^a UR MALY   (France)

^b CIRSEE   (France)

Author keywords

Beta blockers; Biological and physical treatments; Estrogens; Municipal wastewater; Removal rate

Indexed keywords

ACEBUTOLOL; ACTIVATED SLUDGE; ANALYTICAL TECHNIQUES; ATTACHED GROWTH; BETA-BLOCKERS; BIOLOGICAL TREATMENT; ESTROGENIC HORMONES; FREEFORMS; HYDRAULIC RETENTION TIME; MEAN VALUES; MUNICIPAL WASTEWATERS; NADOLOL; OZONATION; PHYSICAL TREATMENTS; POLISHING PONDS; REMOVAL EFFICIENCIES; REMOVAL RATE; ROTATING BIOLOGICAL CONTACTOR; SAMPLING PROCEDURES; SAND FILTRATION; SUSPENDED GROWTH; TARGET MOLECULE; TERTIARY TREATMENT; TREATMENT EFFICIENCY; TREATMENT PROCESS; TRICKLING FILTER; URBAN AREAS; URBAN WASTEWATER; WASTEWATER TREATMENT PLANTS;

ACTIVATED CARBON; ACTIVATED CARBON TREATMENT; BIOFILTRATION; BIOLOGICAL WATER TREATMENT; DATA PROCESSING; DISSOLUTION; EFFLUENTS; MICROFILTRATION; MOLECULES; OZONE; OZONE WATER TREATMENT; OZONIZATION; REMOVAL; SEWAGE PUMPING PLANTS; WASTEWATER; WASTEWATER RECLAMATION; WATER RECYCLING; WATER TREATMENT PLANTS;

WASTEWATER TREATMENT;

ACEBUTOLOL; ACTIVATED CARBON; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETAXOLOL; ESTROGEN DERIVATIVE; NADOLOL; PROPRANOLOL; SOTALOL;

ACCURACY ASSESSMENT; ACTIVATED CARBON; BIOMASS; BIOREACTOR; BIOREMEDIATION; DATA PROCESSING; EFFICIENCY MEASUREMENT; ESTROGENIC COMPOUND; FILTRATION; OSMOSIS; PERFORMANCE ASSESSMENT; RETENTION; WASTEWATER; WATER TREATMENT;

ACCURACY; ACTIVATED SLUDGE; ARTICLE; BIOFILTER; BIOFILTRATION; BIOMASS; CONTROLLED STUDY; EFFLUENT; MICROFILTRATION; OZONATION; POND; PRIORITY JOURNAL; REVERSE OSMOSIS; RURAL AREA; URBAN AREA; WASTE COMPONENT REMOVAL; WASTE WATER TREATMENT PLANT; WATER SAMPLING;

ADRENERGIC BETA-ANTAGONISTS; EFFICIENCY; ENVIRONMENTAL MONITORING; ESTROGENS; SEWAGE; WASTE DISPOSAL, FLUID; WATER POLLUTANTS, CHEMICAL;

FRANCE;

EID: 77954622419     PISSN: 00489697     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.scitotenv.2010.05.023     Document Type: Article

References (43)

1. Adler P., Steger-Hartmann T., Kalbfus W. Distribution of natural and synthetic estrogenic steroid hormones in water samples from Southern and Middle Germany. Acta Hydroch Hydrob 2001, 29(4):227-241.
2. AFNOR Protocole d'évaluation d'une méthode alternative d'analyse physico-chimique par rapport à une méthode de référence 1999, Norme NF XPT 90-210: 58pp.
3. Baronti C., Curini R., D'Ascenzo G., Di Corcia A., Gentili A., Samperi R. Monitoring natural and synthetic estrogens at activated sludge sewage treatment plants and in a receiving river water. Environ Sci Technol 2000, 34(24):5059-5066.
4. Belfroid A.C., Van der Horst A., Vethaak A.D., Schafer A.J., Rijs G.B.J., Wegener J., Cofino W.P. Analysis and occurrence of estrogenic hormones and their glucuronides in surface water and waste water in The Netherlands. Sci Total Environ 1999, 225(1-2):101-108.
5. Bendz D., Paxeus N.A., Ginn T.R., Loge F.J. Occurrence and fate of pharmaceutically active compounds in the environment, a case study: Hoje River in Sweden. J Hazard Mater 2005, 122(3):195-204.
6. Besse J.P., Garric J Médicaments à usage humain: risques d'exposition et effets sur les milieux récepteurs, Rapport Phase 1, Proposition d'une liste de médicaments à usage humain à surveiller dans les eaux de surfaces continentales 2007, Cemagref, Lyon.
7. Besse J.P., Kausch-Barreto C., Garric J. Exposure assessment of pharmaceuticals and their metabolites in the aquatic environment: application to the French situation and preliminary prioritization. Hum Ecol Risk Assess 2008, 14(4):665-695.
8. Carballa M., Omil F., Lema J.M. Removal of cosmetic ingredients and pharmaceuticals in sewage primary treatment. Water Res 2005, 39(19):4790-4796.
9. Castiglioni S., Bagnati R., Fanelli R., Pomati F., Calamari D., Zuccato E. Removal of pharmaceuticals in sewage treatment plants in Italy. Environ Sci Technol 2006, 40(1):357-363.
10. Christensen A.M., Markussen B., Baun A., Halling-Sorensen B. Probabilistic environmental risk characterization of pharmaceuticals in sewage treatment plant discharges. Chemosphere 2009, 77(3):351-358.
11. Czajka C.P., Londry K.L. Anaerobic biotransformation of estrogens. Sci Total Environ 2006, 367(2-3):932-941.
12. D'Ascenzo G., Di Corcia A., Gentili A., Mancini R., Mastropasqua R., Nazzari M., Samperi R. Fate of natural estrogen conjugates in municipal sewage transport and treatment facilities. Sci Total Environ 2003, 302(1-3):199-209.
13. EC Commission Decision of 12 August 2002 implementing Council Directive 96/23/EC concerning the performance of analytical methods and the interpretation of results 2002, 2002/657/EC: 29p.
14. Haider S., Baqri S.S.R. beta-Adrenoceptor antagonists reinitiate meiotic maturation in Clarias batrachus oocytes. Comp Biochem Physiol Mol Integr Physiol 2000, 126(4):517-525.
15. Isobe T., Shiraishi H., Yasuda M., Shinoda A., Suzuki H., Morita M. Determination of estrogens and their conjugates in water using solid-phase extraction followed by liquid chromatography-tandem mass spectrometry. J Chromatogr A 2003, 984(2):195-202.
16. Janex-Habibi M.L., Huyard A., Esperanza M., Bruchet A. Reduction of endocrine disruptor emissions in the environment: the benefit of wastewater treatment. Water Res 2009, 43(6):1565-1576.
17. Jobling S., Nolan M., Tyler C.R., Brighty G., Sumpter J.P. Widespread sexual disruption in wild fish. Environ Sci Technol 1998, 32(17):2498-2506.
18. Joss A., Andersen H., Ternes T., Richle P.R., Siegrist H. Removal of estrogens in municipal wastewater treatment under aerobic and anaerobic conditions: consequences for plant optimization. Environ Sci Technol 2004, 38(11):3047-3055.
19. Labadie P., Budzinski H. Determination of steroidal hormone profiles along the Jalle d'Eysines River (near Bordeaux, France). Environ Sci Technol 2005, 39(14):5113-5120.
20. MEDAD Arrêté du 22 juin 2007 relative à la collecte, au transport et au traitement des eaux usées des agglomérations d'assainissement ainsi qu'à la surveillance de leur fonctionnement et de leur efficacité, et aux dispositifs d'assainissement non collectif recevant une charge brute de pollution organique supérieure à 1.2kg/j de DBO5 2007, DEVO0754085A.
21. Miege C., Choubert J.M., Ribeiro L., Eusebe M., Coquery M. Fate of pharmaceuticals and personal care products in wastewater treatment plants - conception of a database and first results. Environ Pollut 2009, 157(5):1721-1726.
22. Miege C., Bados P., Brosse C., Coquery M. Method validation for the analysis of estrogens (including conjugated compounds) in aqueous matrices. Trends Analyt Chem 2009, 28(2):237-244.
23. Mouatassim-Souali A., Tamisier-Karolak S.L., Perdiz D., Cargouet M., Levi Y. Validation of a quantitative assay using GC/MS for trace determination of free and conjugated estrogens in environmental water samples. J Sep Sci 2003, 26(1-2):105-111.
24. Muller M., Rabenoelina F., Balaguer P., Patureau D., Lemenach K., Budzinski H., Barcelo D., De Alda M.L., Kuster M., Delgenes J.P., Hernandez-Raquet G. Chemical and biological analysis of endocrine-disrupting hormones and estrogenic activity in an advanced sewage treatment plant. Environ Toxicol Chem 2008, 27(8):1649-1658.
25. Nakada N., Tanishima T., Shinohara H., Kiri K., Takada H. Pharmaceutical chemicals and endocrine disrupters in municipal wastewater in Tokyo and their removal during activated sludge treatment. Water Res 2006, 40(17):3297-3303.
26. Paffoni C., Welte B., Gousailles M., Montiel A. Nouvelles molecules mises en cause par les directives européennes: de la station d'épuration à l'usine de traitement d'eau potable. Eur J Water Qual 2006, 37(1):21-38.
27. Pholchan P., Jones M., Donnelly T., Sallis P.J. Fate of estrogens during the biological treatment of synthetic wastewater in a nitrite-accumulating sequencing batch reactor. Environ Sci Technol 2008, 42(16):6141-6147.
28. Piram A., Salvador A., Gauvrit J.Y., Lanteri P., Faure R. Development and optimisation of a single extraction procedure for the LC/MS/MS analysis of two pharmaceutical classes residues in sewage treatment plant. Talanta 2008, 74(5):1463-1475.
29. Piram A., Salvador A., Verne C., Herbreteau B., Faure R. Photolysis of beta-blockers in environmental waters. Chemosphere 2008, 73(8):1265-1271.
30. Radjenovic J., Petrovic M., Barcelo D. Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment. Water Res 2009, 43(3):831-841.
31. Ren H.Y., Ji S.L., Ahmad N.U.D., Dao W., Cui C.W. Degradation characteristics and metabolic pathway of 17 alpha-ethynylestradiol by Sphingobacterium sp JCR5. Chemosphere 2007, 66(2):340-346.
32. Scheurer M., Ramil M., Metcalfe C.D., Groh S., Ternes T.A. The challenge of analyzing beta-blocker drugs in sludge and wastewater. Anal Bioanal Chem 2010, 396:845-856.
33. Serrano D., Lema J.M., Omil F. Influence of the employment of co-precipitation and adsorption agents for the removal of PPCPs in Conventional Activated Sludge (CAS) systems 2009, Xenowac, Paphos, Cyprus.
34. Shi J.H., Suzuki Y., Nakai S., Hosomi M. Mimbial degradation of estrogens using activated sludge and night soil-composting microorganisms. Water Sci Technol 2004, 50(8):153-159.
35. Ternes T.A. Occurrence of drugs in German sewage treatment plants and rivers. Water Res 1998, 32(11):3245-3260.
36. Ternes T.A., Joss A. Human Pharmaceuticals, Hormones and Fragrances: the challenge of micropollutants in urban water management 2006, IWA Publishing.
37. Ternes T.A., Kreckel P., Mueller J. Behaviour and occurrence of estrogens in municipal sewage treatment plants - II. Aerobic batch experiments with activated sludge. Sci Total Environ 1999, 225(1-2):91-99.
38. Triebskorn R., Casper H., Scheil V., Schwaiger J. Ultrastructural effects of pharmaceuticals (carbamazepine, clofibric acid, metoprolol, diclofenac) in rainbow trout (Oncorhynchus mykiss) and common carp (Cyprinus carpio). Anal Bioanal Chem 2007, 387(4):1405-1416.
39. Vader J.S., van Ginkel C.G., Sperling F., de Jong J., de Boer W., de Graaf J.S., van der Most M., Stokman P.G.W. Degradation of ethinyl estradiol by nitrifying activated sludge. Chemosphere 2000, 41(8):1239-1243.
40. Vieno N.M., Tuhkanen T., Kronberg L. Seasonal variation in the occurrence of pharmaceuticals in effluents from a sewage treatment plant and in the recipient water. Environ Sci Technol 2005, 39(21):8220-8226.
41. Vieno N., Tuhkanen T., Kronberg L. Elimination of pharmaceuticals in sewage treatment plants in Finland. Water Res 2007, 41(5):1001-1012.
42. Winter M.J., Lillicrap A.D., Caunter J.E., Schaffner C., Alder A.C., Ramil M., Ternes T.A., Giltrow E., Sumpter J.P., Hutchinson T.H. Defining the chronic impacts of atenolol on embryo-larval development and reproduction in the fathead minnow (Pimephales promelas). Aquat Toxicol 2008, 86(3):361-369.
43. Yoshimoto T., Nagai F., Fujimoto J., Watanabe K., Mizukoshi H., Makino T., Kimura K., Saino H., Sawada H., Omura H. Degradation of estrogens by Rhodococcus zopfii and Rhodococcus equi isolates from activated sludge in wastewater treatment plants. Appl Environ Microbiol 2004, 70(9):5283-5289.